Ir para o conteúdo principal

United States Últimas notícias

Todas as matérias desta categoria, das mais recentes às mais antigas.

Grafa

Halozyme partner J&J wins FDA nod for myeloma combo featuring ENHANZE tech

Halozyme Therapeutics (NASDAQ:HALO) shares were in focus Friday after partner Johnson & Johnson secured U.S. regulatory approval for a subcutaneous combination therapy that significantly reduces the risk of disease progression in patients with relapsed multiple myeloma.

Leia mais: Halozyme partner J&J wins FDA nod for myeloma combo featuring ENHANZE tech
Grafa
Health

PMV Pharmaceuticals secures orphan drug status as ovarian cancer data strengthens

PMV Pharmaceuticals (NASDAQ:PMVP) reported significant clinical momentum for its lead candidate, rezatapopt, bolstered by a fresh FDA Orphan Drug Designation and clinical results showing high response rates in late-stage ovarian cancer patients.

Leia mais: PMV Pharmaceuticals secures orphan drug status as ovarian cancer data strengthens